Paper40938239
Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis.
Milani P and 22 others. JACC CardioOncol, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Diagnostic Performance of the New Free Light Chain Ratio in Systemic Amyloidosis. Papers, record 40938239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40938239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19520758 | Screening panels for detection of monoclonal gammopathies. | Clin Chem | 2009 | https://conductscience.org/library/papers/19520758 | PubMed |
| 2 | 27585505 | Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27585505 | PubMed |
| 3 | 28550043 | AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis. | Blood | 2017 | https://conductscience.org/library/papers/28550043 | PubMed |
| 4 | 32130406 | Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis. | Blood Adv | 2020 | https://conductscience.org/library/papers/32130406 | PubMed |
| 5 | 25044787 | Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. | Hum Mutat | 2014 | https://conductscience.org/library/papers/25044787 | PubMed |
| 6 | 25115890 | A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. | Blood | 2014 | https://conductscience.org/library/papers/25115890 | PubMed |
| 7 | 36621346 | Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM Criteria. | Clin Lymphoma Myeloma Leuk | 2023 | https://conductscience.org/library/papers/36621346 | PubMed |
| 8 | 34001889 | Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. | Blood Cancer J | 2021 | https://conductscience.org/library/papers/34001889 | PubMed |
| 9 | 12194920 | Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. | Clin Chem | 2002 | https://conductscience.org/library/papers/12194920 | PubMed |
| 10 | 38989681 | Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis. | Amyloid | 2024 | https://conductscience.org/library/papers/38989681 | PubMed |
| 11 | 31109193 | Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. | Circulation | 2019 | https://conductscience.org/library/papers/31109193 | PubMed |
| 12 | 21917755 | Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. | Blood | 2012 | https://conductscience.org/library/papers/21917755 | PubMed |
| 13 | 15131802 | Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. | Gastroenterology | 2004 | https://conductscience.org/library/papers/15131802 | PubMed |
| 14 | 28439985 | The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic. | Am J Hematol | 2017 | https://conductscience.org/library/papers/28439985 | PubMed |
| 15 | 28343171 | Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays. | Clin Chem Lab Med | 2017 | https://conductscience.org/library/papers/28343171 | PubMed |
| 16 | 11274017 | Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. | Clin Chem | 2001 | https://conductscience.org/library/papers/11274017 | PubMed |
| 17 | 27143678 | Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. | Circulation | 2016 | https://conductscience.org/library/papers/27143678 | PubMed |
| 18 | 35567705 | Endomyocardial biopsy in the clinical context: current indications and challenging scenarios. | Heart Fail Rev | 2023 | https://conductscience.org/library/papers/35567705 | PubMed |
| 19 | 23091105 | New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/23091105 | PubMed |
| 20 | 36028388 | Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. | Am J Cardiol | 2022 | https://conductscience.org/library/papers/36028388 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42536398 | The light chain hunt: appraising assays in AL amyloidosis. | Blood Adv | 2026 | https://conductscience.org/library/papers/42536398 | PubMed |
| 42397016 | Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management. | Eur J Haematol | 2026 | https://conductscience.org/library/papers/42397016 | PubMed |
| 42305910 | Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging. | Eur Heart J Imaging Methods Pract | 2026 | https://conductscience.org/library/papers/42305910 | PubMed |
| 41995733 | Global validation of revised sFLC cutoffs in amyloidosis. | Blood Adv | 2026 | https://conductscience.org/library/papers/41995733 | PubMed |
| 41955068 | Monoclonal gammopathy exclusion in transthyretin amyloid cardiomyopathy: iStopMM estimated glomerular filtration rate-adjusted serum-free light chain ratio cut-offs. | Eur Heart J | 2026 | https://conductscience.org/library/papers/41955068 | PubMed |
| 41705764 | Reply: Refining Free Light Chain Ratio in Systemic Amyloidosis. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/41705764 | PubMed |
| 41705763 | Refining Free Light Chain Ratio in Systemic Amyloidosis. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/41705763 | PubMed |
| 41130643 | The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis. | JACC CardioOncol | 2025 | https://conductscience.org/library/papers/41130643 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40938239
GET https://conductscience.org/api/papers/v1/40938239/authors?page=2